- Are You A Little Low? Failure To Match Energy Intake With Requirements
As many as one third of women experience symptoms which they believe are caused by low blood glucose (sugar), according to a recent survey conducted in Nottinghamshire (1). The symptoms of such low blood glucose (or hypoglycaemia, as it is medically termed), include: irritability; faintness; tremor; hunger and anxiety. However, it is not known whether such women experience true (biochemically defined) hypoglycaemia or whether their symptoms are caused by some other factor. - Mississippi Blood Services Improves Product Integrity And Delivery With RFID From Texas Instruments
With a short shelf life and cold storage conditions required for its products, Mississippi Blood Services recently completed its first trial using radio frequency identification (RFID) from Texas Instruments Incorporated (NYSE: TXN) (TI) and AARFID to streamline inventory management, strengthen safety procedures and improve hospital delivery. - CuraGen And TopoTarget Announce Initiation Of NCI-sponsored Phase I Clinical Trial Of PXD101
CuraGen Corporation (Nasdaq: CRGN) and TopoTarget A/S (Copenhagen Stock Exchange: TOPO) announced today the initiation of patient dosing in a Phase I clinical trial evaluating the safety and tolerability of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, in combination with azacitidine for the treatment of advanced hematologic malignancies. This trial is being sponsored by the National Cancer Institute (NCI) under a Clinical Trials Agreement with CuraGen for the development of PXD - Medical City Is First North Texas Donor Site For Texas Cord Blood Bank
On Wednesday, August 9, Medical City will become the Texas Cord Blood Bank's first donor site in North Texas -- and the fourth in the state. The Texas Cord Blood Bank, a division of the South Texas Blood & Tissue Center, is a non-profit program established by the Texas legislature in 2001 to collect umbilical cord blood that can benefit patients suffering from a number of potentially fatal diseases. - Einstein's Dr. E. Richard Stanley Receives 2006 E. Donnall Thomas Prize
E. Richard Stanley, Ph.D., professor and chair of developmental and molecular biology at Albert Einstein College of Medicine of Yeshiva University has been selected to receive the 2006 E. Donnall Thomas Prize, presented annually by the American Society of Hematology. - Blood Clot Fibers More Elastic Than Spider's Web
The tiny fibers that comprise blood clots show extraordinary elasticity, on average stretching to almost three times their length while still retaining their ability to go back to their normal shape and expanding to more than four times their length before breaking, according to findings published in the journal Science this week by researchers at Wake Forest University. - Men More At Risk Of Recurrent Blood Clots Than Women
Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in The Lancet. The baseline frequency of recurrent blood clots is 25% after five years. - ACE-ing The Test Of Blood Pressure Regulation
Angiotensin converting enzyme 2 (ACE2) is expressed at its highest levels in the kidney and heart, suggesting a potential role in the regulation of the cardiovascular system. - Test Helps Identify Patients At Low Risk For Recurring Blood Clots
A test that measures the generation of a certain protein involved with blood clotting can help determine whether patients who have experienced a venous blood clot are at low risk of developing another blood clot, and thus avoiding anticoagulant treatment and its possible side effects, according to a study in the July 26 issue of JAMA. - FDA Clears Body Fluids Analysis Application For Sysmex XT-Series
Sysmex America, Inc. announced today that the Body Fluid application on the Sysmex XT-2000i(TM) and Sysmex XT-1800 (TM) Automated Hematology Analyzers has been cleared by the United States Food and Drug Administration (FDA) for the analysis of cerebrospinal fluid (CSF), serous and synovial fluids, said John Kershaw, President, Sysmex America, Inc. The XT-series analyzer is an instrument designed for mid volume laboratories.
|
